https://www.selleckchem.com/products/c646.html
In multivariable Cox regression analysis, Tenascin-C (adjusted hazard ratio [HR] 1.755, 95% confidence interval [CI] 1.305-2.360; 0.0001) and indexed extracellular volume (HR 1.465, CI 1.019-2.106; = 0.039) were independently associated with adverse outcomes. In HFpEF, plasma Tenascin-C is higher compared to age- and sex-matched controls and a strong predictor of adverse outcomes. ClinicalTrials.gov NCT03050593. In HFpEF, plasma Tenascin-C is higher compared to age- and sex-matched controls and a strong predictor of adverse outcomes
Like
Comment
Share
